Human anti-rhesus D IgG1 antibody produced in transgenic plants

被引：27

作者：

Bouquin, T

Thomsen, M

Nielsen, LK

Green, TH

Mundy, J

Dziegiel, MH

机构：

[1] Univ Copenhagen Hosp, HS Blodbanken, DK-2100 Copenhagen O, Denmark

[2] Univ Copenhagen, Inst Mol Biol, Dept Plant Physiol, DK-1353 Copenhagen, Denmark

来源：

TRANSGENIC RESEARCH | 2002年 / 11卷 / 02期

关键词：

alloimmunization; immunoglobulin; Rhesus; transgenic plants;

D O I：

10.1023/A:1015226418688

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Transgenic plants represent an alternative to cell culture systems for producing cheap and safe antibodies for diagnostic and therapeutic use. To evaluate the functional properties of a 'plantibody', we generated transgenic Arabidopsis plants expressing full-length human IgG1 against the Rhesus D antigen, which is responsible for alloimmunization of RhD- mothers carrying an RhD+ fetus. Anti-RhD extracted from plants specifically reacted with RhD+ cells in antiglobulin technique, and elicited a respiratory burst in human peripheral blood mononuclear cells. Plant-derived antibody had equivalent properties to CHO cell-produced anti-RhD antibody, indicating its potential usefulness in diagnostic and therapeutic programs.

引用

页码：115 / 122

页数：8

共 34 条

[1] Galactose-extended glycans of antibodies produced by transgenic plants
Bakker, H
Bardor, M
Molthoff, JW
Gomord, V
Elbers, I
Stevens, LH
Jordi, W
Lommen, A
Faye, L
Lerouge, P
Bosch, D
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2899 - 2904
[2] BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194
[3] COMBINATORIAL AND SYNERGISTIC PROPERTIES OF CAMV 35S-ENHANCER SUBDOMAINS
BENFEY, PN
REN, L
CHUA, NH
[J]. EMBO JOURNAL, 1990, 9 (06) : 1685 - 1696
[4] N-glycosylation of a mouse IgG expressed in transgenic tobacco plants
Cabanes-Macheteau, M
Fitchette-Lainé, AC
Loutelier-Bourhis, C
Lange, C
Vine, ND
Ma, JKC
Lerouge, P
Faye, L
[J]. GLYCOBIOLOGY, 1999, 9 (04) : 365 - 372
[5] A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice
Chargelegue, D
Vine, ND
van Dolleweerd, CJ
Drake, PMW
Ma, JKC
[J]. TRANSGENIC RESEARCH, 2000, 9 (03) : 187 - 194
[6] Gene silencing results in instability of antibody production in transgenic plants
De Neve M.
De Buck S.
De Wilde C.
Van Houdt H.
Strobbe I.
Jacobs A.
Van Montagu M.
Depicker A.
[J]. Molecular and General Genetics MGG, 1999, 260 (6): : 582 - 592
[7] PHAGE DISPLAY USED FOR GENE CLONING OF HUMAN RECOMBINANT ANTIBODY AGAINST THE ERYTHROCYTE SURFACE-ANTIGEN, RHESUS-D
DZIEGIEL, M
NIELSEN, LK
ANDERSEN, PS
BLANCHER, A
DICKMEISS, E
ENGBERG, J
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 182 (01) : 7 - 19
[8] Molecular farming of pharmaceutical proteins
Fischer, R
Emans, N
[J]. TRANSGENIC RESEARCH, 2000, 9 (4-5) : 279 - 299
[9] N-glycans harboring the Lewis a epitope are expressed at the surface of plant cells
Fitchette-Lainé, AC
Gomord, V
Cabanes, M
Michalski, JC
Saint Macary, M
Foucher, B
Cavelier, B
Hawes, C
Lerouge, P
Faye, L
[J]. PLANT JOURNAL, 1997, 12 (06) : 1411 - 1417
[10] Transgenic plants as factories for biopharmaceuticals
Giddings, G
Allison, G
Brooks, D
Carter, A
[J]. NATURE BIOTECHNOLOGY, 2000, 18 (11) : 1151 - 1155

← 1 2 3 4 →